BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 33032902)

  • 1. Molecular events in the pathogenesis of vulvar squamous cell carcinoma.
    Xing D; Fadare O
    Semin Diagn Pathol; 2021 Jan; 38(1):50-61. PubMed ID: 33032902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome.
    Tessier-Cloutier B; Pors J; Thompson E; Ho J; Prentice L; McConechy M; Aguirre-Hernandez R; Miller R; Leung S; Proctor L; McAlpine JN; Huntsman DG; Gilks CB; Hoang LN
    Mod Pathol; 2021 Feb; 34(2):508-518. PubMed ID: 32792599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.
    Zięba S; Kowalik A; Zalewski K; Rusetska N; Goryca K; Piaścik A; Misiek M; Bakuła-Zalewska E; Kopczyński J; Kowalski K; Radziszewski J; Bidziński M; Góźdź S; Kowalewska M
    Gynecol Oncol; 2018 Sep; 150(3):552-561. PubMed ID: 29980281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic Approach.
    Yang H; Almadani N; Thompson EF; Tessier-Cloutier B; Chen J; Ho J; Senz J; McConechy MK; Chow C; Ta M; Cheng A; Karnezis A; Huvila J; McAlpine JN; Gilks B; Jamieson A; Hoang LN
    Mod Pathol; 2023 Jun; 36(6):100145. PubMed ID: 36828360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CA.
    Watkins JC; Howitt BE; Horowitz NS; Ritterhouse LL; Dong F; MacConaill LE; Garcia E; Lindeman NI; Lee LJ; Berkowitz RS; Nucci MR; Crum CP
    Mod Pathol; 2017 Mar; 30(3):448-458. PubMed ID: 27834349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status.
    Tessier-Cloutier B; Kortekaas KE; Thompson E; Pors J; Chen J; Ho J; Prentice LM; McConechy MK; Chow C; Proctor L; McAlpine JN; Huntsman DG; Gilks CB; Bosse T; Hoang LN
    Mod Pathol; 2020 Aug; 33(8):1595-1605. PubMed ID: 32203095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiated Vulvar Intraepithelial Neoplasia-like and Lichen Sclerosus-like Lesions in HPV-associated Squamous Cell Carcinomas of the Vulva.
    Rakislova N; Alemany L; Clavero O; Del Pino M; Saco A; Quirós B; Lloveras B; Alejo M; Halec G; Quint W; de Sanjosé S; Ordi J;
    Am J Surg Pathol; 2018 Jun; 42(6):828-835. PubMed ID: 29505429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma.
    Trietsch MD; Spaans VM; ter Haar NT; Osse EM; Peters AA; Gaarenstroom KN; Fleuren GJ
    Gynecol Oncol; 2014 Oct; 135(1):149-55. PubMed ID: 25072932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy.
    Clancy AA; Spaans JN; Weberpals JI
    Ann Oncol; 2016 Sep; 27(9):1696-705. PubMed ID: 27329249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vulvar squamous cell carcinoma arising on human papillomavirus-independent precursors mimicking high-grade squamous intra-epithelial lesion: a distinct and highly recurrent subtype of vulvar cancer.
    Carreras-Dieguez N; Saco A; Del Pino M; Pumarola C; Del Campo RL; Manzotti C; Garcia A; Marimon L; Diaz-Mercedes S; Fuste P; Rodrigo-Calvo MT; Vega N; Torné A; Rakislova N
    Histopathology; 2023 Apr; 82(5):731-744. PubMed ID: 36593525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic Mutation Profiling in Premalignant Lesions of Vulvar Squamous Cell Carcinoma.
    Zięba S; Pouwer AW; Kowalik A; Zalewski K; Rusetska N; Bakuła-Zalewska E; Kopczyński J; Pijnenborg JMA; de Hullu JA; Kowalewska M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and epigenetic changes in vulvar squamous cell carcinoma and its precursor lesions: a review of the current literature.
    Trietsch MD; Nooij LS; Gaarenstroom KN; van Poelgeest MI
    Gynecol Oncol; 2015 Jan; 136(1):143-57. PubMed ID: 25448458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vulvar Squamous Cell Carcinoma (VSCC) as Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3.
    Weberpals JI; Lo B; Duciaume MM; Spaans JN; Clancy AA; Dimitroulakos J; Goss GD; Sekhon HS
    Clin Cancer Res; 2017 Aug; 23(15):4501-4510. PubMed ID: 28377483
    [No Abstract]   [Full Text] [Related]  

  • 14. Differentiated vulvar intraepithelial neoplasia contains Tp53 mutations and is genetically linked to vulvar squamous cell carcinoma.
    Pinto AP; Miron A; Yassin Y; Monte N; Woo TY; Mehra KK; Medeiros F; Crum CP
    Mod Pathol; 2010 Mar; 23(3):404-12. PubMed ID: 20062014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma.
    Dongre HN; Elnour R; Tornaas S; Fromreide S; Thomsen LCV; Kolseth IBM; Nginamau ES; Johannessen AC; Vintermyr OK; Costea DE; Bjørge L
    Acta Obstet Gynecol Scand; 2024 Jan; 103(1):165-175. PubMed ID: 37840151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-grade vulvar intraepithelial neoplasia: comprehensive characterization and long-term vulvar carcinoma risk.
    Thuijs NB; van Beurden M; Duin S; Heideman DAM; Berkhof J; Steenbergen RDM; Bleeker MCG
    Histopathology; 2024 Jan; 84(2):301-314. PubMed ID: 37726173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma.
    Del Pino M; Rodriguez-Carunchio L; Ordi J
    Histopathology; 2013 Jan; 62(1):161-75. PubMed ID: 23190170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16 Immunostaining Allows for Accurate Subclassification of Vulvar Squamous Cell Carcinoma Into HPV-Associated and HPV-Independent Cases.
    Cheng AS; Karnezis AN; Jordan S; Singh N; McAlpine JN; Gilks CB
    Int J Gynecol Pathol; 2016 Jul; 35(4):385-93. PubMed ID: 26630231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding the Morphologic, Immunohistochemical, and HPV Genotypic Features of High-grade Squamous Intraepithelial Lesions of the Vulva With Morphology Mimicking Differentiated Vulvar Intraepithelial Neoplasia and/or Lichen Sclerosus.
    Griesinger LM; Walline H; Wang GY; Lorenzatti Hiles G; Welch KC; Haefner HK; Lieberman RW; Skala SL
    Int J Gynecol Pathol; 2021 May; 40(3):205-213. PubMed ID: 32925443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status.
    Kortekaas KE; Santegoets SJ; Abdulrahman Z; van Ham VJ; van der Tol M; Ehsan I; van Doorn HC; Bosse T; van Poelgeest MIE; van der Burg SH
    J Immunother Cancer; 2019 Sep; 7(1):236. PubMed ID: 31481117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.